Obatoclax, a Pan-BCL-2 Inhibitor, Downregulates Survivin to Induce Apoptosis in Human Colorectal Carcinoma Cells Via Suppressing WNT/β-catenin Signaling

Colorectal cancer (CRC) is a highly prevailing cancer and the fourth leading cause of cancer mortality worldwide. Aberrant expression of antiapoptotic BCL-2 family proteins is closely linked to neoplastic progression and chemoresistance. Obatoclax is a clinically developed drug, which binds antiapop...

Descripción completa

Detalles Bibliográficos
Autores principales: Or, Chi-Hung R., Huang, Chiao-Wen, Chang, Ching-Chin, Lai, You-Chen, Chen, Yi-Ju, Chang, Chia-Che
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7084590/
https://www.ncbi.nlm.nih.gov/pubmed/32150830
http://dx.doi.org/10.3390/ijms21051773

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7084590/
https://www.ncbi.nlm.nih.gov/pubmed/32150830
http://dx.doi.org/10.3390/ijms21051773

Ejemplares similares